{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:23:27Z","timestamp":1792808607638,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12350-018-01504-y","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T15:38:52Z","timestamp":1542037132000},"page":"2003-2010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis"],"prefix":"10.1016","volume":"27","author":[{"given":"R.J.","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-01504-y_bib1","first-page":"298","article-title":"Isolated cardiac sarcoidosis-A rare disease entity?","volume":"25","author":"Schindler","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-01504-y_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000489","article-title":"Current management of sarcoidosis I","author":"West","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1007\/s12350-018-01504-y_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the Ameri","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1007\/s12350-018-01504-y_bib4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jcmg.2017.11.006","article-title":"The challenges of diagnosing cardiac sarcoidosis","volume":"10","author":"Blankstein","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1007\/s12350-018-01504-y_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1007\/s12350-018-01504-y_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Hear Rhythm."},{"key":"10.1007\/s12350-018-01504-y_bib7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-018-01504-y_bib8","article-title":"FDG-PET\/CT Imaging in the Management of Cardiac Sarcoidosis Serial","author":"Bremer","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-018-01504-y_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-01504-y_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01504-y_bib11","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death","author":"Al-Khatib","year":"2017","journal-title":"Hear Rhythm"},{"key":"10.1007\/s12350-018-01504-y_bib12","unstructured":"Gregoratos G, Cheitlin MD, Conill A, et al. ACC\/AHA Practice Guidelines ACC\/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Commit. 1991."},{"issue":"7","key":"10.1007\/s12350-018-01504-y_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"10.1007\/s12350-018-01504-y_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1007\/s12350-018-01504-y_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01504-y_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodoexyglucose positron emission tomography?","volume":"6","author":"McArdle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-01504-y_bib17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01504-y_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","article-title":"Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis","volume":"7","author":"Ishiyama","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-018-01504-y_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-01504-y_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: Characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol."},{"key":"10.1007\/s12350-018-01504-y_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"key":"10.1007\/s12350-018-01504-y_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-01504-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:08:24Z","timestamp":1761026904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123020639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1071358123020639"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-01504-y","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-01504-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}